Monaldi Hospital Rhythm Registry

Sponsor
University of Campania "Luigi Vanvitelli" (Other)
Overall Status
Recruiting
CT.gov ID
NCT05072119
Collaborator
(none)
5,000
1
419.8
11.9

Study Details

Study Description

Brief Summary

The study is a prospective registry. Consecutive patients with indications of implant / replacement or upgrade of pacemaker (PM), implantable cardioverter defibrillator (ICD), Implanted loop recorder (ILR) will be enrolled.

The primary objective of the study is to describe the clinical events during a long-term follow-up of non-selected population of patients implanted with an PM, ICD or ILR.

Condition or Disease Intervention/Treatment Phase
  • Device: Device implantation

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Registry of Patients Underwent Cardiac Implanted Electronic Device Implantation at Monaldi Hospital
Actual Study Start Date :
Jan 7, 2015
Anticipated Primary Completion Date :
Jan 7, 2030
Anticipated Study Completion Date :
Jan 1, 2050

Arms and Interventions

Arm Intervention/Treatment
Patients with PM

All patients underwent PM implantation

Device: Device implantation
Implantation of single chamber, dual chambers or triple chambers PM/ICD

Patients with ICD

All patients undeerwent ICD implantation

Device: Device implantation
Implantation of single chamber, dual chambers or triple chambers PM/ICD

Patients with ILR

All patients underwent ILR implantation

Device: Device implantation
Implantation of single chamber, dual chambers or triple chambers PM/ICD

Outcome Measures

Primary Outcome Measures

  1. CIEDs Infection [through study completion, an average of 1 year]

    The number of patecipants with infections following implantation of cardiac implantable electronic devices

  2. Appropriate ICD Therapies Antitachycardia pacing therapy or shock delivered by ICD for device detected ventricular arrhythmia [through study completion, an average of 1 year]

    The number of partecipants with a least one episode of antitachycardia pacing therapy or shock delivered by ICD for device detected ventricular arrhythmias.

  3. Inappropriate ICD Therapies [through study completion, an average of 1 year]

    The number of partecipants with at least one episode of antitachycardia pacing therapy or shock delivered by ICD for device detected sopraventricular arrhythmias.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All consecutive patients underwent PM/ICD/ILR implantation

  • Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent

  • Patient must be able to attend all required follow-up visits at the study center for at least 12 months

Exclusion Criteria:
  • No informed consent

  • Patient is participating in another clinical study that may have an impact on the study endpoint

Exclusion Criteria:
  • No informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vincenzo Russo Naples Napoli Italy 80136

Sponsors and Collaborators

  • University of Campania "Luigi Vanvitelli"

Investigators

  • Study Chair: Vincenzo Russo, MD PhD, University of Campania "Luigi Vanvitelli"

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vincenzo Russo, Principal Investigator, University of Campania "Luigi Vanvitelli"
ClinicalTrials.gov Identifier:
NCT05072119
Other Study ID Numbers:
  • 22052021
First Posted:
Oct 8, 2021
Last Update Posted:
Oct 15, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 15, 2021